Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H13N5O4 |
Molecular Weight | 267.2413 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
InChI
InChIKey=OIRDTQYFTABQOQ-KQYNXXCUSA-N
InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
Molecular Formula | C10H13N5O4 |
Molecular Weight | 267.2413 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:31 UTC 2023
by
admin
on
Fri Dec 15 15:17:31 UTC 2023
|
Record UNII |
K72T3FS567
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
496 (Number of products:57)
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
LOINC |
75136-2
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
WHO-ATC |
C01EB10
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
FDA ORPHAN DRUG |
32388
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
NCI_THESAURUS |
C707
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
LOINC |
75142-0
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
WHO-VATC |
QC01EB10
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
NDF-RT |
N0000178375
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
NDF-RT |
N0000175788
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
||
|
LOINC |
75160-2
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID1022558
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
296
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00640
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
16335
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
D000241
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
SUB00297MIG
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
ADENOSINE
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
K72T3FS567
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
2844
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
100000078834
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
K72T3FS567
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
m1411
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
7774
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
60961
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
CHEMBL477
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
90
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
200-389-9
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
1012123
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
C207
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
7652
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY | |||
|
58-61-7
Created by
admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
Reduces the production of adenosine
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Adenosine is broken down by adenosine deaminase, which is present in red cells and the vessel wall.
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.6; impurity G = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.6; impurity G = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |